Research Article
Impact of Prediabetes and Type-2 Diabetes on Outcomes in Patients with COVID-19
Table 7
Binomial regression for mortality in the patients with diabetes mellitus.
| | Odds ratio | value |
| Previously diagnosed diabetes mellitus | 3.50 (1.45–8.46) | 0.005 | Age | 1.02 (1.01–1.04) | 0.003 | BMI | 1.00 (0.97–1.02) | 0.751 | Black | 0.00 (0.00–0.00) | 0.224 | Caucasian | 1.04 (0.54–2.01) | 0.902 | Hispanic | 0.95 (0.22–4.10) | 0.945 | Others | 1.50 (0.81–2.77) | 0.200 | Hypertension | 0.77 (0.49–1.21) | 0.260 | Antiviral medication | 1.11 (0.59–2.09) | 0.752 | Remdesivir | 0.36 (0.06–2.18) | 0.265 | Anticonvalescent plasma | 2.07 (0.64–6.71) | 0.224 | Steroids | 0.34 (0.24–0.50) | ≤0.001 | Tocilizumab | 1.36 (0.69–2.65) | 0.374 |
|
|